Stroke: Disappointing results for clazosentan in CONSCIOUS-2

[1]  S. Mayer,et al.  Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2) , 2011, The Lancet Neurology.

[2]  B. Kieseier,et al.  A critical appraisal of treatment decisions in multiple sclerosis—old versus new , 2011, Nature Reviews Neurology.

[3]  R. Macdonald,et al.  Dissociation of Vasospasm and Secondary Effects of Experimental Subarachnoid Hemorrhage by Clazosentan , 2011, Stroke.

[4]  S. Mayer,et al.  Angiographic Vasospasm Is Strongly Correlated With Cerebral Infarction After Subarachnoid Hemorrhage , 2011, Stroke.

[5]  Jan Claassen,et al.  Quantitative Analysis of Hemorrhage Volume for Predicting Delayed Cerebral Ischemia After Subarachnoid Hemorrhage , 2011, Stroke.

[6]  C. Iadecola,et al.  Spreading depolarization: a possible new culprit in the delayed cerebral ischemia of subarachnoid hemorrhage. , 2011, Archives of neurology.

[7]  P. Rothwell,et al.  Time trends in outcome of subarachnoid hemorrhage , 2010, Neurology.

[8]  Ludwig Kappos,et al.  Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. , 2010, The New England journal of medicine.

[9]  V. Morra,et al.  COMBINING BETA INTERFERON AND ATORVASTATIN MAY INCREASE DISEASE ACTIVITY IN MULTIPLE SCLEROSIS , 2009, Neurology.

[10]  P. Calabresi,et al.  Effect of statins on clinical and molecular responses to intramuscular interferon beta-1a , 2009, Neurology.

[11]  E. Stroes,et al.  Microthrombosis after Aneurysmal Subarachnoid Hemorrhage: An Additional Explanation for Delayed Cerebral Ischemia , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[12]  R. Macdonald.  Clazosentan: an endothelin receptor antagonist for treatment of vasospasm after subarachnoid hemorrhage , 2008 .

[13]  H. Hartung,et al.  Statins — a cure-all for the brain? , 2005, Nature Reviews Neuroscience.

[14]  S. Youssef,et al.  The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease , 2002, Nature.

[15]  V. Seifert,et al.  Endothelin related pathophysiology in cerebral vasospasm: what happens to the cerebral vessels? , 2011, Acta neurochirurgica. Supplement.

[16]  F. Fazekas,et al.  CME Statins as immunomodulators Comparison with interferon-1 b in MS , 2002 .